Logo-jrip
Submitted: 07 Feb 2021
Accepted: 14 Apr 2021
ePublished: 18 May 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Renal Inj Prev. 2022;11(1): e6-e6.
doi: 10.34172/jrip.2022.06
  Abstract View: 479
  PDF Download: 242

Original

Serum fetuin-A levels and its relationship with biochemical parameters in hemodialysis patients

Behzad Abbasi Jamaati 1 ORCID logo, Raheb Ghorbani 2 ORCID logo, Mehrdad Zahmatkesh 1 ORCID logo, Mohammad Reza Tamadon 1 * ORCID logo

1 Department of Internal Medicine, Semnan University of Medical Sciences, Semnan, Iran
2 Social Determinants of Health Research Center, Semnan University of Medical Sciences, Semnan, Iran
*Corresponding author: Mohammad Reza Tamadon, Email: mrt_tamadon@yahoo.com, dr.tamadon@semums.ac.ir

Abstract

Introduction: Cardiovascular events are the most important complications of end-stage renal disease (ESRD). The role of fetuin-A and vascular calcification inhibitors in cardiovascular complications, dysregulated biochemical markers, and mortality is uncertain in patients under hemodialysis.

Objectives: The aim of this study was to investigate the relationship of fetuin-A with cardiovascular complications and biochemical markers in hemodialysis patients.

Patients and Methods: In this cross-sectional study, 65 patients undergoing hemodialysis were enrolled. Blood samples were taken at pre-dialysis to determine serum fetuin-A, calcium, phosphorus, intact parathyroid hormone (iPTH), C-reactive protein (CRP), albumin, triglyceride, total cholesterol, as well as blood hemoglobin, and hematocrit. The data was analyzed considering the statistical significance level of 0.05.

Results: Out of 65 patients, seven patients died during the study, and 58 patients were finally evaluated. Mean (±SD) serum fetuin-A level was 1268.71 ± 1229.4 μg/mL. There was no significant difference in the mean fetuin-A level between genders (P=0.904). There were no significant correlations between the serum level of fetuin-A and age, duration of dialysis, heart diseases, serum levels of calcium, phosphorus, PTH, albumin, CRP, cholesterol and finally blood hemoglobin. However, significant relationships were found between fetuin-A level and serum triglyceride (TG) level (P=0.019) and body mass index (BMI) (P=0.024).

Conclusion: Fetuin-A level was significantly associated with serum TG level and BMI. Regarding the links of obesity and hypertriglyceridemia with cardiovascular diseases (CVDs), controlling serum TG level and body weight can reduce the risk of vascular atherosclerosis in patients undergoing dialysis.

Keywords: Hemodialysis, Fetuin A, Chronic kidney disease, End-stage renal disease

Implication for health policy/practice/research/medical education:

End-stage renal disease (ESRD) is often associated with several complications. An important matter in these patients is early diagnosis of complications and prevention of their progression. Given the possible relationship between fetuin-A in hemodialysis patients with inhibitors of vascular calcification, atherosclerosis and biochemical markers and the pathogenesis factors involved in atherosclerosis, by confirming the relationship between biochemical markers and fetuin-A and the effect on vascular calcification it may be possible to reduce complications in hemodialysis patients.

Please cite this paper as: Abbasi Jamaati B, Ghorbani R, Zahmatkesh M, Tamadon MR. Serum fetuin-A levels and its relationship with biochemical parameters in hemodialysis patients. J Renal Inj Prev. 2022; 11(1): e06. doi: 10.34172/jrip.2022.06.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 479

Your browser does not support the canvas element.


PDF Download: 242

Your browser does not support the canvas element.